BRKR vs GMED

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

BRKR

40.6
AI Score
VS
GMED Wins

GMED

53.9
AI Score

Investment Advisor Scores

BRKR

41score
Recommendation
HOLD

GMED

54score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BRKR GMED Winner
Forward P/E 13.8313 13.8696 BRKR
PEG Ratio 1.5155 1.7253 BRKR
Revenue Growth 5.2% 5.9% GMED
Earnings Growth -81.8% -26.2% GMED
Tradestie Score 40.6/100 53.9/100 GMED
Profit Margin -2.0% 17.0% GMED
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

BRKR 1M: +7.7% · 3M: +3.6% GMED 1M: -6.0% · 3M: -5.8%

Current Technical Phase

BRKR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.2 · Price: $63.54

GMED

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.6 · Price: $75.83

Fundamentals Snapshot

Metric BRKR GMED
Market Cap — —
Forward P/E 26.5 14.0
Trailing P/E — 19.2
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.7%
Operating Margin 0.1% 0.2%
EPS -0.75 3.88
Dividend Yield 0.00% —

Frequently Asked Questions

Based on our detailed analysis, GMED is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.